South Africa has signed a deal with pharmaceutical giant Novartis to collaborate in research and clinical trials.
The agreement between the South African Medical Research Council, the Department of Science and Technology and the company was signed on 25 May in Cape Town.
The collaboration falls under the SAMRC Strategic Health Innovation Partnerships, which focuses on developing medicines and medical devices.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.